Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2007
10/31/2007EP1848742A1 Anti-prl-3 antibodies and methods of use thereof
10/31/2007EP1848741A1 Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats o11 serotype
10/31/2007EP1848740A1 Monoclonal antibodies that bind or neutralize hepatitis b virus
10/31/2007EP1848739A2 Adamts-7 as a biomarker for cancers of epithelial origin
10/31/2007EP1848737A2 Homogeneous preparations of il-31
10/31/2007EP1848672A2 Libraries and methods for isolating antibodies
10/31/2007EP1848504A2 Wound treatment device for photodynamic therapy and method of using same
10/31/2007EP1848458A1 Use of activated polymers for separation of protein and polypeptide multimers
10/31/2007EP1848410A1 Polymer particle delivery compositions and methods of use
10/31/2007EP1692179A4 An antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same
10/31/2007EP1509606B1 Allergen from mugwort pollen
10/31/2007EP1372691B1 Mucin peptide with immunoenhancing properties
10/31/2007EP1240298B1 Detergent compositions comprising benefit agents
10/31/2007EP1192247B9 Sphingosine kinase enzyme
10/31/2007EP1177312B1 Human gil-19/ae289 proteins and polynucleotides encoding same
10/31/2007EP1165791B1 Human cytokine as ligand of the zalpha receptor and uses thereof
10/31/2007EP1078004B1 Tetravalent antibody constructs
10/31/2007EP1011707B1 HIV-1 gp120 V1/V2 DOMAIN EPITOPES CAPABLE OF GENERATING NEUTRALIZING ANTIBODIES
10/31/2007EP0998576B1 Method for producing a recombinant bovine adenovirus vector
10/31/2007EP0871645B1 Modulators of the function of fas/apo1 receptors
10/31/2007EP0851030B9 PROTEIN SPECIFIC TO HUMAN Th2, GENE (B19) ENCODING THE SAME, AND TRANSFORMANT, RECOMBINANT VECTOR AND MONOCLONAL ANTIBODY RELATING THERETO
10/31/2007CN101065402A Process for obtaining antibodies
10/31/2007CN101065147A Naturally occurring IgM antibodies that bind lymphocytes
10/31/2007CN101063147A Yeast expression carrier for recombined bone sialic acid protein and its application
10/31/2007CN101063146A Yeast expression carrier for combined bone sialic acid protein, purification method and its application
10/31/2007CN101063143A Recombined cytomegalovirus gp52 protein and its application
10/31/2007CN101062949A Recombinant anti human IgE monoclonal antibody and preparation method and usage thereof
10/31/2007CN101062413A Method for preparing anti-dog parvovirus egg yolk antibody biological preparation
10/31/2007CN101062009A Therapeutikum mit einem botulinum-neurotoxin
10/31/2007CN100345966C Human acid fibroblast growth factor resistant single-chain antibody gene
10/30/2007US7288646 USPA2 nucleic acid of Moraxella catarrhalis
10/30/2007US7288638 Fully human antibodies against human 4-1BB
10/30/2007US7288637 Single chain antibody against mutant p53
10/30/2007US7288636 Forms of prostate specific antigens and methods for their detection
10/30/2007US7288635 Antibodies to a testis-specific differentiation-regulatory factor
10/30/2007US7288634 Isolated antibodies immunoreactive with synthetic peptides used to detect rheumatoid arthritis
10/30/2007US7288633 To induce the activities of B cells and T cells in therapy of immune deficiency disorders, viral infections, and bacterial infections
10/30/2007US7288628 PRO20088 polypeptides
10/30/2007US7288627 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for releasing tumor necrosis factor from blood; for modulating uptake of glucose by skeletal muscle cells; for stimulating release of proteoglycans from cartilage
10/30/2007US7288626 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/30/2007US7288398 Molecules
10/30/2007US7288390 Anti-dual integrin antibodies, compositions, methods and uses
10/30/2007US7288381 Group 2 allergen specific IgE-Fabs and use thereof
10/30/2007US7288375 Introducing one or more mutations into a template double-stranded polynucleotide via hybridization, replication and amplification of random genomic double stranded and heterozygous oligonucleotides sequences; genomics and directed evolution
10/30/2007US7288255 Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells
10/30/2007US7288254 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
10/30/2007US7288253 Antibodies directed to parathyroid hormone (PTH) and uses thereof
10/30/2007US7288252 Administering antigen , or antagonist antibody; binding; antiproliferative agents; controlling cell differentiation
10/30/2007US7288251 Antibodies to CD40
10/30/2007US7288250 Monoclonal antibodies against HMGB1
10/30/2007US7288249 Antibodies for cancer therapy and diagnosis
10/30/2007US7288248 Antibodies against cancer antigen TMEFF2 and uses thereof
10/30/2007US7288247 Binding antibody to epitopes
10/30/2007CA2272356C Soluble polypeptides
10/30/2007CA2150378C Mammalian muscle nad:arginine adp-ribosyltransferase
10/25/2007WO2007121354A2 Binding proteins comprising immunoglobulin hinge and fc regions having altered fc effector functions
10/25/2007WO2007121233A1 Methods of treating autoimmune diseases
10/25/2007WO2007120767A2 Agonist erythropoietin receptor antibodies
10/25/2007WO2007120693A2 Targeted binding agents directed to upar and uses thereof
10/25/2007WO2007119796A1 Mutant polypeptide having effector function
10/25/2007WO2007119787A1 Phosphatase involved in the regulation of cardiomyocyte differentiation
10/25/2007WO2007119759A1 Dopamine-producing neuron progenitor cell marker 187a5
10/25/2007WO2007119563A1 Human megalin determination method
10/25/2007WO2007119518A1 Anti-methylated dna antibody and method for production thereof
10/25/2007WO2007119515A1 Novel tumor antigen peptides
10/25/2007WO2007119279A1 Dna vaccine for koi herpes virus (khv) disease
10/25/2007WO2007118986A2 Concentrate of immunoglobulins and f(ab)'2 and/or fab fragments specific of an arbovirus as medicine
10/25/2007WO2007118670A1 Dp-78-like nanobodies
10/25/2007WO2007118423A1 Human recombinant erytheropoietin fusion proteins, preparing methods and uses thereof
10/25/2007WO2007096142A3 Vascular tumor markers
10/25/2007WO2007095318A3 Influenza antigens, vaccine compositions, and related methods
10/25/2007WO2007086994A9 Single chain fragment of monoclonal antibody 9b9 and uses thereof
10/25/2007WO2007011968A3 Beta-glucuronide-linker drug conjugates
10/25/2007WO2006099308A3 A method of weak partitioning chromatography
10/25/2007WO2002099074A3 Slc7s as modifiers of the p53 pathway and methods of use
10/25/2007US20070250956 modulating expression of a GATA transcription factor gene in the plant cell; modulates agronomic traits such as improved fertilizer untilization (nitrogen utilization), crop yield, lipid biosynthesis
10/25/2007US20070250939 Mannose Binding Lectin Knock-Out Mice and Methods of Use Thereof
10/25/2007US20070249814 Transcriptional regulatory factor
10/25/2007US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes)
10/25/2007US20070249812 Methods for Stabilizing Protein Solutions
10/25/2007US20070249533 Il-17a and il-17f antagonists and methods of using the same
10/25/2007US20070249529 Compositions Comprising Polypeptides
10/25/2007US20070249020 Cytokine zcytor17 ligand polypeptides and polynucleotides
10/25/2007US20070249005 Gastrin hormone immunoassays
10/25/2007US20070248972 Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
10/25/2007US20070248963 method for identifying pre-neoplastic and/or neoplastic states in mammals
10/25/2007US20070248616 Canine Respiratory Coronavirus (Crcv) Spike Protein, Polymerase and Hemagglutinin/Esterase
10/25/2007US20070248613 Human Antibodies Interacting with Hiv Gp41
10/25/2007US20070248609 Therapeutic Method
10/25/2007US20070248608 Monoclonal Antibodies to Progastrin
10/25/2007US20070248606 Treatment of Alzheimer's disease
10/25/2007US20070248605 Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic Intervention
10/25/2007US20070248604 Inhibits fibroblast growth factor (FGF); used to treat a tumor, a cancer, and/or a cell proliferative disorder
10/25/2007US20070248603 Immunoglobulin fusion with enhanced affinity for Fc gamma RIIa; tissue targeted therapy; immunotherapy; directed protein evolution
10/25/2007US20070248602 Fc Variants Having Increased Affinity for FcyRllc
10/25/2007US20070248601 Non-Human Transgenic Mammal for the Constant Region of the Class a Human Immunoglobulin Heavy Chain and Applications Thereof
10/25/2007US20070248600 selection of a CHO (chinese hamster ovary) cell that recombinantly produces an Fc region expressed and glycosylated monoclonal antibody comprising human IgG1 or IgG3 heavy chain constant domains; for manufacture of a medicament
10/25/2007US20070248598 Recombinant anti-VLA4 antibody molecules
10/25/2007US20070248593 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods
10/25/2007US20070248588 Novel Compositions and Methods for the Treatment of Immune-Related Diseases
1 ... 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 ... 1494